Evidence map›Paper›PMID 37409883›Full record

ArticlePsychological medicine2023

Prevalence of cognitive impairments and strengths in the early course of psychosis and depression.

Alexandra Stainton, Katharine Chisholm, Siân Lowri Griffiths, Lana Kambeitz-Ilankovic, Julian Wenzel, Carolina Bonivento, Paolo Brambilla, Mariam Iqbal, Theresa K Lichtenstein, Marlene Rosen and 21 more

Open access · hybridAbstract read
In one paragraph

Article in Psychological medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 15 institutions in 7 countries.

Alexandra StaintonOrygen, Melbourne, Victoria, Australia.ORCID 0000-0002-4969-3122
Katharine ChisholmSchool of Psychology, Aston University, Birmingham, UK.
Siân Lowri GriffithsInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Lana Kambeitz-IlankovicDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Julian WenzelDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Carolina BoniventoScientific Institute, IRCCS E. Medea, Pasian di Prato, Udine, Italy.
Paolo BrambillaDepartment of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Mariam IqbalDepartment of Psychology, Woodbourne Priory Hospital, Birmingham, UK.
Theresa K LichtensteinDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Marlene RosenDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Linda A AntonucciDepartment of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari "Aldo Moro", Bari, Italy.
Eleonora MaggioniDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Joseph KambeitzDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Stefan BorgwardtDepartment of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
Anita Riecher-RösslerMedical Faculty, University of Basel, Basel, Switzerland.
Christina AndreouDepartment of Psychiatry, Psychiatric University Hospital, University of Basel, Basel, Switzerland.
André SchmidtDepartment of Psychiatry, Psychiatric University Hospital, University of Basel, Basel, Switzerland.
Frauke Schultze-LutterDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Eva MeisenzahlDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Stephan RuhrmannDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Raimo K R SalokangasDepartment of Psychiatry, University of Turku, Turku, Finland.
Christos PantelisMelbourne Neuropsychiatry Centre, University of Melbourne and Melbourne Health, Melbourne, VIC, Australia.
Rebekka LencerDepartment of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
Georg RomerDepartment of Child Adolescent Psychiatry and Psychotherapy, University of Münster, Münster, Germany.
Alessandro BertolinoDepartment of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari "Aldo Moro", Bari, Italy.
Rachel UpthegroveInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Kelly AllottOrygen, Melbourne, Victoria, Australia.
Stephen J WoodOrygen, Melbourne, Victoria, Australia.
PRONIA Consortium
PRONIA Consortium
University Hospital Cologne · DEThe University of Melbourne · AUUniversity of Basel · CHCentre for Mental Health · GBUniversity of Bari Aldo Moro · ITUniversity of Münster · DEAston University · GBHeinrich Heine University Düsseldorf · DEIRCCS Eugenio Medea · ITKing's College London · GBLudwig-Maximilians-Universität München · DEThe Priory Hospital · GBUniversity of Bern · CHUniversity of Milan · ITUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies investigating cognitive impairments in psychosis and depression have typically compared the average performance of the clinical group against healthy controls (HC), and do not report on the actual

methodsA comprehensive cognitive test battery comprising 12 tests was completed by 1286 individuals aged 15-41 (mean age 25.07, s.d. 5.88) from the PRONIA study at baseline: HC (

resultsImpairment in at least two cognitive tests was as follows: ROP (88.3% moderately, 45.1% severely impaired), CHR (71.2% moderately, 22.4% severely impaired), ROD (61.6% moderately, 16.2% severely impaired). Across clinical groups, impairments were most prevalent in tests of working memory, processing speed, and verbal learning. Above average performance (>1 s.d.) in at least two tests was present for 40.5% ROD, 36.1% CHR, 16.1% ROP, and was >2 SDs in 1.8% ROD, 1.4% CHR, and 0% ROP.

conclusionsThese findings suggest that interventions should be tailored to the individual, with working memory, processing speed, and verbal learning likely to be important transdiagnostic targets.

Indexed as

Cognition DisordersCognitive DysfunctionPsychotic DisordersAdultDepressionHumansNeuropsychological TestsPrevalenceMental healthprocessing speedpsychosisverbal learningworking memory

Identifiers

PMID37409883
PMCPMC10520593
OpenAlexW4383302981

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.